Wednesday, 31 May 2017

Teva's migraine drug succeeds in late-stage study

(Reuters) - Teva Pharmaceutical Industries Ltd said on Wednesday its experimental drug to prevent migraine met the main goal in a late-stage study.


Congo reports outbreaks of severe bird flu in Ituri: OIE

PARIS (Reuters) - The Democratic Republic of Congo has reported three outbreaks of highly pathogenic H5 bird flu among poultry in the northeastern province of Ituri, the World Organisation for Animal Health (OIE) said on Wednesday.


Cancer meeting to provide clues on future immunotherapy combos

(Reuters) - As a wider range of drugs that enlist the body's immune system to fight cancer become available, clues about which combinations will prove most effective are expected at the upcoming meeting of the American Society of Clinical Oncology.